Reunion Neuroscience Inc (REUN) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access REUN quarterly Cash Flow →
This page allows investors to follow Reunion Neuroscience Inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
Annual Report, GAAP in USD millions
ITEM
(Mar 31 2023)
12 Months
(Mar 31 2021)
Operating Activities
Income-37.15
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.57
Financial Instruments and Foreign Currency Transaction-0.19
Adjustments For Depreciation And Amortisation Expense0.92
Adjustments For Sharebased Payments2.17
Adjustments For Gain Loss On Disposal Of Investments In Subsidiaries Joint Ventures And Associates-
Adjustments For Interest Income-0.53
Adjustments For Interest Expense0.45
Increase Decrease In Working Capital2.52
Cash Flows Excluded From Used In Operating Activities-21.44
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities0.01
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities32.76
Discontinued operations0.00
Net Cash flow from Operating Activities-21.12
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds From Sales Or Maturity Of Financial Instruments Classified As Investing Activities5.89
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Purchase Of Financial Instruments Classified As Investing Activities5.89
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-5.83
Discontinued operations0.00
Net Cash Flow from Investing Activities-5.75
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.01
Other net-50.42
Proceeds From Exercise Of Warrants-
Ifrs Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents49.40
Restricted Cash And Cash Equivalents0.40
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.61
Effect of exchange rate on cash flow-27.83
Discontinued operations3.18
Free Cash Flow-21.12
Total Cash Flow20.84
4 historic quarters locked

Sign in to unlock the full Reunion Neuroscience Inc cash flow history.

About Reunion Neuroscience Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-23-011551

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License